▶ 調査レポート

豚ワクチンの世界市場分析・規模・シェア・成長・動向・予測:適応症別(下痢、豚インフルエンザ、関節炎、ボルデテラ鼻炎、豚繁殖・呼吸障害症候群 (PRRS)、豚サーコウイルス感染症(PCVAD))、最終用途別(動物病院、豚の生産農場)、技術別(不活化ワクチン、弱毒生ワクチン、トキソイドワクチン、組換えワクチン、結合体ワクチン、DNAワクチン)

• 英文タイトル:Porcine Vaccines Market (Disease Indication - Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated Disease (PCVAD); End use - Veterinary Hospitals and Hog Production Farms; Technology - Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Transparency Market Researchが調査・発行した産業分析レポートです。豚ワクチンの世界市場分析・規模・シェア・成長・動向・予測:適応症別(下痢、豚インフルエンザ、関節炎、ボルデテラ鼻炎、豚繁殖・呼吸障害症候群 (PRRS)、豚サーコウイルス感染症(PCVAD))、最終用途別(動物病院、豚の生産農場)、技術別(不活化ワクチン、弱毒生ワクチン、トキソイドワクチン、組換えワクチン、結合体ワクチン、DNAワクチン) / Porcine Vaccines Market (Disease Indication - Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated Disease (PCVAD); End use - Veterinary Hospitals and Hog Production Farms; Technology - Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 / TPM-B05079資料のイメージです。• レポートコード:TPM-B05079
• 出版社/出版日:Transparency Market Research / 2018年4月11日
• レポート形態:英文、PDF、240ページ
• 納品方法:Eメール
• 産業分類:Pharmaceutical
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Global Site License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、豚ワクチンの世界市場について調べ、豚ワクチンの世界規模、市場動向、市場環境、適応症別(下痢、豚インフルエンザ、関節炎、ボルデテラ鼻炎、豚繁殖・呼吸障害症候群 (PRRS)、豚サーコウイルス感染症(PCVAD))分析、最終用途別(動物病院、豚の生産農場)分析、技術別(不活化ワクチン、弱毒生ワクチン、トキソイドワクチン、組換えワクチン、結合体ワクチン、DNAワクチン)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・豚ワクチンの世界市場動向
・豚ワクチンの世界市場環境
・豚ワクチンの世界市場規模
・豚ワクチンの世界市場規模:適応症別(下痢、豚インフルエンザ、関節炎、ボルデテラ鼻炎、豚繁殖・呼吸障害症候群 (PRRS)、豚サーコウイルス感染症(PCVAD))
・豚ワクチンの世界市場規模:最終用途別(動物病院、豚の生産農場)
・豚ワクチンの世界市場規模:技術別(不活化ワクチン、弱毒生ワクチン、トキソイドワクチン、組換えワクチン、結合体ワクチン、DNAワクチン)
・豚ワクチンの世界市場:地域別市場規模・分析
・豚ワクチンの北米市場規模・予測
・豚ワクチンのアメリカ市場規模・予測
・豚ワクチンの中南米市場規模・予測
・豚ワクチンのヨーロッパ市場規模・予測
・豚ワクチンのアジア市場規模・予測
・豚ワクチンの日本市場規模・予測
・豚ワクチンの中国市場規模・予測
・豚ワクチンのインド市場規模・予測
・豚ワクチンの中東市場規模・予測
・豚ワクチンのアフリカ市場規模・予測
・競争状況・関連企業情報

Porcine Vaccines Market – Overview

This report on the porcine vaccines market analyzes the current and future scenario of the global market. Increase in the prevalence of diseases among swine, technological advancements of RNA strand methodology, and cultivation of pigs to raise standards of living are likely to drive the global porcine vaccines market during the forecast period. Increase in the number of trading facilities for live hogs/pigs, rise in the demand for pork meat, and innovations through clinical research activities are some of the factors expected to drive the global porcine vaccines market during the forecast period.

This report on the global porcine vaccines market comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the market with respect to segments based on disease indication, technology, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises Porter’s five forces analysis to help understand the competition landscape of the market. This section also provides market attractiveness analysis, in terms of country, and market share analysis, by key players, thereby presenting a thorough analysis of the overall competition scenario in the global porcine vaccines market.

Based on technology, the porcine vaccines market has been segmented into inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and DNA vaccines. These market segments have been extensively analyzed based on increase in the demand for treatment of diseases such as PED, PRRS, and PCVAD. Surging demand for disease-free pork meat and increasing awareness for treating cultivated pigs are driving the technology segments of the market. Different types of end-users utilize porcine vaccines to treat swine diseases. Among end-users, the hog production farms segment holds a major share, followed by the veterinary hospitals segment. The market size (in terms of US$ Mn) and forecast for each segment have been provided for the period from 2015 to 2025. The report also provides the compounded annual growth rate (CAGR %) for each segment for the period from 2017 to 2025, considering 2016 as the base year.

Based on disease indication, the market has been segmented into diarrhoea, swine influenza, porcine reproductive and respiratory syndrome (PRRS), porcine circovirus associated disease (PCVAD), and others. Diarrhoea is the most widespread disease among pigs across the world. Porcine epidemic diarrhea virus (PEDV) hit the U.S. in 2013 and spread to Canada in 2014, which infected piglets. It had 80%–100% mortality rate. The above-mentioned segments have been analyzed based on available approved products, their cost-effectiveness, and preference by veterinarians for treating swine with various disease indications. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global porcine vaccines market has been categorized into five major regions and key countries/sub-regions in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, Russia, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2015 to 2025, along with their respective CAGRs for the period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competition scenario in the market in these regions.

The report also profiles major players in the global porcine vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report are Bayer AG., Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Santé Animale, Elanco (Eli Lilly and Company), Merck & Co., Inc., Vetoquinol, and Zoetis Inc.

The global porcine vaccines market has been segmented as below:

Global Porcine Vaccines Market, by Disease Indication, 2015–2025

Diarrhea
Swine Influenza
Arthritis
Bordetella Rhinitis
Porcine Reproductive and Respiratory Syndrome (PRRS)
Porcine Circovirus Associated Disease (PCVAD)
Others (CHRS, Leptospirosis, etc.)
Global Porcine Vaccines Market, by Technology, 2015–2025

Inactivated Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
DNA Vaccines
Global Porcine Vaccines Market, by End-user, 2015–2025

Veterinary Hospitals
Hog Production Farms
Global Porcine Vaccines Market, by Geography, 2015–2025

North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Rest of Middle East & Africa

レポート目次

Chapter 1.Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2.Assumptions and Research Methodology

Chapter 3.Executive Summary : Global Porcine Vaccines Market

Chapter 4.Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Market Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Porcine Vaccines Market Analysis and Forecast, 2015–2025
4.4.1. Market Revenue Projection (US$ Mn)
4.5. Porter’s Five Forces Analysis
4.6. Market Outlook
4.7.Regulatory Scenario Assessment
4.7.1. North America
4.7.2. Europe
4.7.3. Asia Pacific
4.8.Disease Indication Comparison, by Region
4.8.1. North America
4.8.2. Europe
4.8.3. Asia Pacific
4.8.4. Latin America
4.8.5. Middle East & Africa
4.9.Swine Production Level, by Region/State
4.9.1. North America
4.9.2. Europe
4.9.3. Asia Pacific
4.9.4. Latin America
4.10.Product Launches and Innovations
4.11. Recent Market Activities
4.12.Introduction of New Types of Vaccines
4.13. Snapshot of Market Trends and Issues

Chapter 5.Global Porcine Vaccines Market Analysis and Forecast, by End-user
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Value Forecast by End-user, 2015–2025
5.3.1. Inactivated Vaccines
5.3.2. Live Attenuated Vaccines
5.3.3. Toxoid Vaccines
5.3.4. Recombinant Vaccines
5.3.5. Conjugate Vaccines
5.3.6. DNA Vaccines
5.4. Market Attractiveness, by End-user

Chapter 6.Global Porcine Vaccines Market Analysis and Forecast, by Disease Indication
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Disease Indication, 2015–2025
6.3.1. Diarrhea
6.3.2. Swine Influenza
6.3.3. Arthritis
6.3.4. Bordetella Rhinitis
6.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS)
6.3.6. Porcine Circovirus Associated Disease (PCVAD)
6.3.7. Others
6.4. Market Attractiveness, by Disease Indication

Chapter 7.Global Porcine Vaccines Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2015–2025
7.3.1. Veterinary Hospitals
7.3.2. Hog Production Farms
7.4. Market Attractiveness, by End-user

Chapter 8.Global Porcine Vaccines Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region

Chapter 9.North America Porcine Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by End-user, 2015–2025
9.2.1. Inactivated Vaccines
9.2.2. Live Attenuated Vaccines
9.2.3. Toxoid Vaccines
9.2.4. Recombinant Vaccines
9.2.5. Conjugate Vaccines
9.2.6. DNA Vaccines
9.3. Market Value Forecast, by Disease Indication, 2015–2025
9.3.1. Diarrhea
9.3.2. Swine Influenza
9.3.3. Arthritis
9.3.4. Bordetella Rhinitis
9.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS)
9.3.6. Porcine Circovirus Associated Disease (PCVAD)
9.3.7. Others
9.4. Market Value Forecast, by End-user, 2015–2025
9.4.1. Veterinary Hospitals
9.4.2. Hog Production Farms
9.5. Market Value Forecast, by Country, 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By End-user
9.6.2. By Disease Indication
9.6.3. By End-user
9.6.4. By Country

Chapter 10.Europe Porcine Vaccines Market Analysis and Forecast
10.1.Introduction
10.1.1. Key Findings
10.2.Market Value Forecast, by End-user, 2015–2025
10.2.1. Inactivated Vaccines
10.2.2. Live Attenuated Vaccines
10.2.3. Toxoid Vaccines
10.2.4. Recombinant Vaccines
10.2.5. Conjugate Vaccines
10.2.6. DNA Vaccines
10.3.Market Value Forecast, by Disease Indication, 2015–2025
10.3.1. Diarrhea
10.3.2. Swine Influenza
10.3.3. Arthritis
10.3.4. Bordetella Rhinitis
10.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS)
10.3.6. Porcine Circovirus Associated Disease (PCVAD)
10.3.7. Others
10.4.Market Value Forecast, by End-user, 2015–2025
10.4.1. Veterinary Hospitals
10.4.2. Hog Production Farms
10.5.Market Value Forecast, by Country/Sub-region, 2015–2025
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Russia
10.5.7. Rest of Europe
10.6.Market Attractiveness Analysis
10.6.1. By End-user
10.6.2. By Disease Indication
10.6.3. By End-user
10.6.4. By Country/Sub-region

Chapter 11.Asia Pacific Porcine Vaccines Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by End-user, 2015–2025
11.2.1. Inactivated Vaccines
11.2.2. Live Attenuated Vaccines
11.2.3. Toxoid Vaccines
11.2.4. Recombinant Vaccines
11.2.5. Conjugate Vaccines
11.2.6. DNA Vaccines
11.3.Market Value Forecast, by Disease Indication, 2015–2025
11.3.1. Diarrhea
11.3.2. Swine Influenza
11.3.3. Arthritis
11.3.4. Bordetella Rhinitis
11.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS)
11.3.6. Porcine Circovirus Associated Disease (PCVAD)
11.3.7. Others
11.4.Market Value Forecast, by End-user, 2015–2025
11.4.1. Veterinary Hospitals
11.4.2. Hog Production Farms
11.5.Market Value Forecast, by Country/Sub-region, 2015–2025
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6.Market Attractiveness Analysis
11.6.1. By End-user
11.6.2. By Disease Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region

Chapter 12.Latin America Porcine Vaccines Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by End-user, 2015–2025
12.2.1. Inactivated Vaccines
12.2.2. Live Attenuated Vaccines
12.2.3. Toxoid Vaccines
12.2.4. Recombinant Vaccines
12.2.5. Conjugate Vaccines
12.2.6. DNA Vaccines
12.3.Market Value Forecast, by Disease Indication, 2015–2025
12.3.1. Diarrhea
12.3.2. Swine Influenza
12.3.3. Arthritis
12.3.4. Bordetella Rhinitis
12.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS)
12.3.6. Porcine Circovirus Associated Disease (PCVAD)
12.3.7. Others
12.4.Market Value Forecast, by End-user, 2015–2025
12.4.1. Veterinary Hospitals
12.4.2. Hog Production Farms
12.5.Market Value Forecast, by Country/Sub-region, 2015–2025
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6.Market Attractiveness Analysis
12.6.1. By End-user
12.6.2. By Disease Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region

Chapter 13.Middle East & Africa Porcine Vaccines Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by End-user, 2015–2025
13.2.1. Inactivated Vaccines
13.2.2. Live Attenuated Vaccines
13.2.3. Toxoid Vaccines
13.2.4. Recombinant Vaccines
13.2.5. Conjugate Vaccines
13.2.6. DNA Vaccines
13.3.Market Value Forecast, by Disease Indication, 2015–2025
13.3.1. Diarrhea
13.3.2. Swine Influenza
13.3.3. Arthritis
13.3.4. Bordetella Rhinitis
13.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS)
13.3.6. Porcine Circovirus Associated Disease (PCVAD)
13.3.7. Others
13.4.Market Value Forecast, by End-user, 2015–2025
13.4.1. Veterinary Hospitals
13.4.2. Hog Production Farms
13.5.Market Value Forecast, by Country/Sub-region, 2015–2025
13.5.1. South Africa
13.5.2. Rest of Middle East & Africa
13.6.Market Attractiveness Analysis
13.6.1. By End-user
13.6.2. By Disease Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region

Chapter 14.Competition Landscape
14.1.Market Player – Competition Matrix (by Tier and Size of companies)
14.2.Market Share Analysis, by Company (2016)
14.2.1. Bayer AG
14.2.1.1. Overview
14.2.1.2. Financials
14.2.1.3. Recent Developments
14.2.1.4. Strategy
14.2.2. Bimeda Animal Health
14.2.2.1. Overview
14.2.2.2. Financials
14.2.2.3. Recent Developments
14.2.2.4. Strategy
14.2.2. Boehringer Ingelheim GmbH
14.2.3.1. Overview
14.2.3.2. Financials
14.2.3.3. Recent Developments
14.2.3.4. Strategy
14.2.4. Ceva Santé Animale
14.2.4.1. Overview
14.2.4.2. Financials
14.2.4.3. Recent Developments
14.2.4.4. Strategy
14.2.5. Elanco (Eli Lilly and Company)
14.2.5.1. Overview
14.2.5.2. Financials
14.2.5.3. Recent Developments
14.2.5.4. Strategy
14.2.6. Merck & Co., Inc.
14.2.6.1. Overview
14.2.6.2. Financials
14.2.6.3. Recent Developments
14.2.6.4. Strategy
14.2.7. Vetoquinol
14.2.7.1. Overview
14.2.7.2. Financials
14.2.7.3. Recent Developments
14.2.7.4. Strategy
14.2.8. Zoetis, Inc.
14.2.8.1. Overview
14.2.8.2. Financials
14.2.8.3. Recent Developments
14.2.8.4. Strategy
14.2.9. Others

List of Tables

Table 01: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 02: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 03: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 04: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 07: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 08: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 09: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 10: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 11: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 12: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 13: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 14: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 15: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 16: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 17: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 18: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 19: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 20: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 21: Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 22: Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 23: Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 24: Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025